Biodexa Pharmaceuticals (BDRX) Change in Taxes (2013 - 2022)
Biodexa Pharmaceuticals (BDRX) posted Change in Taxes of -$327918.4 for Q3 2021, up 43.43% sequentially from -$579678.0 in Q4 2020, and up 40.68% YoY from -$233090.2 in Q3 2020.
Biodexa Pharmaceuticals (BDRX) Change in Taxes (2013 - 2022) Analysis & Trends
Biodexa Pharmaceuticals has reported Change in Taxes for 7 years, with the latest figure at -$327918.4 in Q3 2021.
- Quarterly Change in Taxes rose 40.68% year-over-year to -$327918.4 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was -$2.5 million (up 82.82% YoY) and the FY2025 annual result came in at -$138443.6, up 56.85% from the prior year.
- Change in Taxes advanced to -$327918.4 in Q3 2021 per BDRX's latest filing, from -$579678.0 in the prior quarter.
- Over five years, Change in Taxes peaked at -$327918.4 in Q3 2021 and troughed at -$1.1 million in Q4 2019.
- A 3-year average of -$632535.9 and a median of -$566251.0 in 2020 frame the typical range for Change in Taxes.
- The sharpest annual moves came in 2020 and 2021: Change in Taxes soared 45.81% in 2020, then surged 40.68% in 2021.
- Over 3 years, Change in Taxes stood at -$1.1 million in 2019, then soared by 45.81% to -$579678.0 in 2020, then jumped by 43.43% to -$327918.4 in 2021.
- According to Business Quant data, Change in Taxes over the past three periods registered -$327918.4, -$579678.0, and -$552824.1 for Q3 2021, Q4 2020, and Q3 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Biodexa Pharmaceuticals | 64,325.41 | -11.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -395,276.84 |
| Dec 31, 2022 | -395,276.84 |
| Sep 17, 2021 | -327,918.44 |
| Sep 17, 2021 | -327,918.44 |
| Dec 31, 2020 | -579,677.99 |
| Dec 31, 2020 | -579,677.99 |
| Sep 10, 2020 | -552,824.08 |
| Sep 10, 2020 | -552,824.08 |
| Dec 31, 2019 | -1.07 Mn |
| Dec 31, 2019 | -1.07 Mn |
| Dec 31, 2016 | -11.39 Mn |
| Dec 31, 2016 | -11.39 Mn |
| Dec 31, 2015 | -1.72 Mn |
| Dec 31, 2015 | -1.72 Mn |
| Dec 31, 2014 | -1.61 Mn |
| Dec 31, 2014 | -1.61 Mn |
| Dec 31, 2013 | -1.29 Mn |
| Dec 31, 2013 | -1.29 Mn |